Related Experiment Video
Updated: Mar 22, 2026
05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
2.6K
Pathophysiology of septic shock: From bench to bedside
Kevin W McConnell1, Craig M Coopersmith1
1Emory University School of Medicine, Emory Critical Care Center, Department of Surgery, Atlanta, GA, United States.
Presse Medicale (Paris, France : 1983)
|April 18, 2016
Summary
Despite advances in understanding sepsis pathophysiology, effective treatments remain elusive. This review explores immunopathologic abnormalities and therapeutic strategies for sepsis, aiming for precision medicine to improve patient outcomes.
Area of Science:
- Critical care medicine
- Immunology
- Pathophysiology
Background:
- Sepsis knowledge has advanced, but clinical trial success is limited.
- Sepsis mortality has decreased due to improved antibiotic and hemodynamic support protocols.
- Translating sepsis pathophysiology research to bedside treatments remains a challenge.
Purpose of the Study:
- To review the immunopathologic abnormalities in sepsis.
- To explore potential therapeutic strategies targeting these abnormalities.
- To highlight the role of precision medicine in improving sepsis outcomes.
Main Methods:
- Literature review of sepsis pathophysiology and immunopathology.
- Analysis of current and potential therapeutic approaches.
- Discussion of precision medicine applications in critical care for sepsis.
Main Results:
- Significant knowledge exists regarding sepsis pathophysiology.
- Clinical trials have yielded limited positive results.
- Educational campaigns on timely interventions have improved survival rates.
Conclusions:
- Further compliance with evidence-based practices is essential.
- A deeper scientific understanding of host response is critical for novel therapeutics.
- Precision medicine offers a path toward individualized and improved sepsis treatment outcomes.
